 Business Wire India In a move that is likely to bring relief to a huge number of breast cancer patients, Alkem Oncology recently announced the launch of the breast cancer drug, Palbociclib under the brand name, Palbo. Palbo which contains Palbociclib, is recommended by the National Comprehensive Cancer Network NCCN-2022 as a first-line treatment for... The post Alkem Launches Novel Breast Cancer Treatment Drug Palbociclib in India appeared first on DKODING... 